Investment analysts at Goldman Sachs (GS) initiated coverage on shares of PharMerica Corporation (PMC) in a note issued to investors on Thursday. The firm set a ‘Neutral’ rating and a $29.00 price target on the stock implying 11.71% expected return from the name’s current pps. PharMerica Corporation shares are currently priced at 58.87x this year’s […]
View the full post at: Pharmerica Corp (PMC) Coverage Initiated by Analysts at Goldman